Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Buy
56
HIMS Quote, Financials, Valuation and Earnings
Last price:
$32.87
Seasonality move
:
2.28%
Day range:
$31.02 - $34.94
52-week range:
$11.20 - $72.98
Dividend yield:
0%
P/E ratio:
62.74x
P/S ratio:
5.43x
P/B ratio:
15.79x
Volume:
17.6M
Avg. volume:
30.6M
1-year change:
116.62%
Market cap:
$7.5B
Revenue:
$1.5B
EPS (TTM):
$0.54
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HIMS
Hims & Hers Health
|
$470.5M | $0.22 | 92.4% | 312.9% | $44.16 |
|
EWCZ
European Wax Center
|
$52.2M | $0.06 | -3.47% | -6.25% | $6.31 |
|
GROV
Grove Collaborative Holdings
|
$48.8M | -$0.15 | -12.21% | -60% | $2.50 |
|
KVUE
Kenvue
|
$3.8B | $0.26 | -5.39% | 54.63% | $24.00 |
|
SKIN
The Beauty Health
|
$77.4M | -$0.09 | -21.04% | -30% | $1.58 |
|
WALD
Waldencast PLC
|
$70.7M | -$0.06 | -- | -- | $5.56 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HIMS
Hims & Hers Health
|
$33.88 | $44.16 | $7.5B | 62.74x | $0.00 | 0% | 5.43x |
|
EWCZ
European Wax Center
|
$4.28 | $6.31 | $185.5M | 19.11x | $0.00 | 0% | 0.92x |
|
GROV
Grove Collaborative Holdings
|
$1.60 | $2.50 | $63M | -- | $0.00 | 0% | 0.29x |
|
KVUE
Kenvue
|
$23.53 | $24.00 | $45B | 44.40x | $0.21 | 3.46% | 2.93x |
|
SKIN
The Beauty Health
|
$1.32 | $1.58 | $165.3M | -- | $0.00 | 0% | 0.55x |
|
WALD
Waldencast PLC
|
$3.20 | $5.56 | $393.1M | -- | $0.00 | 0% | 1.35x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HIMS
Hims & Hers Health
|
-- | 7.338 | -- | 1.38x |
|
EWCZ
European Wax Center
|
85.49% | -1.418 | 115.69% | 1.58x |
|
GROV
Grove Collaborative Holdings
|
31.62% | 1.822 | 9.44% | 0.73x |
|
KVUE
Kenvue
|
46.77% | 1.501 | 20.79% | 0.65x |
|
SKIN
The Beauty Health
|
91.42% | 0.014 | 278% | 5.85x |
|
WALD
Waldencast PLC
|
21.71% | -0.007 | 29.49% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HIMS
Hims & Hers Health
|
$369.5M | $18.6M | 32.03% | 32.03% | 3.87% | $59.5M |
|
EWCZ
European Wax Center
|
$37M | $12.8M | 2.18% | 9.76% | 16.01% | $16.3M |
|
GROV
Grove Collaborative Holdings
|
$25.9M | -$8.3M | -39.61% | -154.22% | -22.3% | -$95K |
|
KVUE
Kenvue
|
$2.1B | $557M | 5.43% | 9.84% | 13.49% | $661M |
|
SKIN
The Beauty Health
|
$52.3M | -$7.2M | -4.33% | -47.95% | -11.09% | $15.6M |
|
WALD
Waldencast PLC
|
-- | -- | -7.46% | -9.22% | -- | -- |
Hims & Hers Health vs. Competitors
-
Which has Higher Returns HIMS or EWCZ?
European Wax Center has a net margin of 5.41% compared to Hims & Hers Health's net margin of 3.96%. Hims & Hers Health's return on equity of 32.03% beat European Wax Center's return on equity of 9.76%.
Company Gross Margin Earnings Per Share Invested Capital HIMSHims & Hers Health76.81% $0.11 $476.7M EWCZEuropean Wax Center74.34% $0.04 $468.8M -
What do Analysts Say About HIMS or EWCZ?
Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 30.35%. On the other hand European Wax Center has an analysts' consensus of $6.31 which suggests that it could grow by 47.49%. Given that European Wax Center has higher upside potential than Hims & Hers Health, analysts believe European Wax Center is more attractive than Hims & Hers Health.
Company Buy Ratings Hold Ratings Sell Ratings HIMSHims & Hers Health4 7 1 EWCZEuropean Wax Center3 5 1 -
Is HIMS or EWCZ More Risky?
Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HIMS or EWCZ?
Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios HIMS or EWCZ?
Hims & Hers Health quarterly revenues are $481.1M, which are larger than European Wax Center quarterly revenues of $49.7M. Hims & Hers Health's net income of $26M is higher than European Wax Center's net income of $2M. Notably, Hims & Hers Health's price-to-earnings ratio is 62.74x while European Wax Center's PE ratio is 19.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 5.43x versus 0.92x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HIMSHims & Hers Health5.43x 62.74x $481.1M $26M EWCZEuropean Wax Center0.92x 19.11x $49.7M $2M
-
Which has Higher Returns HIMS or GROV?
Grove Collaborative Holdings has a net margin of 5.41% compared to Hims & Hers Health's net margin of -25.53%. Hims & Hers Health's return on equity of 32.03% beat Grove Collaborative Holdings's return on equity of -154.22%.
Company Gross Margin Earnings Per Share Invested Capital HIMSHims & Hers Health76.81% $0.11 $476.7M GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M -
What do Analysts Say About HIMS or GROV?
Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 30.35%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.50 which suggests that it could grow by 56.25%. Given that Grove Collaborative Holdings has higher upside potential than Hims & Hers Health, analysts believe Grove Collaborative Holdings is more attractive than Hims & Hers Health.
Company Buy Ratings Hold Ratings Sell Ratings HIMSHims & Hers Health4 7 1 GROVGrove Collaborative Holdings2 0 0 -
Is HIMS or GROV More Risky?
Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HIMS or GROV?
Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HIMS or GROV?
Hims & Hers Health quarterly revenues are $481.1M, which are larger than Grove Collaborative Holdings quarterly revenues of $49.5M. Hims & Hers Health's net income of $26M is higher than Grove Collaborative Holdings's net income of -$12.6M. Notably, Hims & Hers Health's price-to-earnings ratio is 62.74x while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 5.43x versus 0.29x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HIMSHims & Hers Health5.43x 62.74x $481.1M $26M GROVGrove Collaborative Holdings0.29x -- $49.5M -$12.6M
-
Which has Higher Returns HIMS or KVUE?
Kenvue has a net margin of 5.41% compared to Hims & Hers Health's net margin of 8%. Hims & Hers Health's return on equity of 32.03% beat Kenvue's return on equity of 9.84%.
Company Gross Margin Earnings Per Share Invested Capital HIMSHims & Hers Health76.81% $0.11 $476.7M KVUEKenvue56.53% $0.15 $18.2B -
What do Analysts Say About HIMS or KVUE?
Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 30.35%. On the other hand Kenvue has an analysts' consensus of $24.00 which suggests that it could grow by 2.01%. Given that Hims & Hers Health has higher upside potential than Kenvue, analysts believe Hims & Hers Health is more attractive than Kenvue.
Company Buy Ratings Hold Ratings Sell Ratings HIMSHims & Hers Health4 7 1 KVUEKenvue3 12 0 -
Is HIMS or KVUE More Risky?
Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HIMS or KVUE?
Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.46% to investors and pays a quarterly dividend of $0.21 per share. Hims & Hers Health pays -- of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend.
-
Which has Better Financial Ratios HIMS or KVUE?
Hims & Hers Health quarterly revenues are $481.1M, which are smaller than Kenvue quarterly revenues of $3.7B. Hims & Hers Health's net income of $26M is lower than Kenvue's net income of $293M. Notably, Hims & Hers Health's price-to-earnings ratio is 62.74x while Kenvue's PE ratio is 44.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 5.43x versus 2.93x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HIMSHims & Hers Health5.43x 62.74x $481.1M $26M KVUEKenvue2.93x 44.40x $3.7B $293M
-
Which has Higher Returns HIMS or SKIN?
The Beauty Health has a net margin of 5.41% compared to Hims & Hers Health's net margin of -12.37%. Hims & Hers Health's return on equity of 32.03% beat The Beauty Health's return on equity of -47.95%.
Company Gross Margin Earnings Per Share Invested Capital HIMSHims & Hers Health76.81% $0.11 $476.7M SKINThe Beauty Health62.69% -$0.08 $604M -
What do Analysts Say About HIMS or SKIN?
Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 30.35%. On the other hand The Beauty Health has an analysts' consensus of $1.58 which suggests that it could grow by 19.32%. Given that Hims & Hers Health has higher upside potential than The Beauty Health, analysts believe Hims & Hers Health is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings HIMSHims & Hers Health4 7 1 SKINThe Beauty Health0 7 0 -
Is HIMS or SKIN More Risky?
Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HIMS or SKIN?
Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HIMS or SKIN?
Hims & Hers Health quarterly revenues are $481.1M, which are larger than The Beauty Health quarterly revenues of $83.5M. Hims & Hers Health's net income of $26M is higher than The Beauty Health's net income of -$10.3M. Notably, Hims & Hers Health's price-to-earnings ratio is 62.74x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 5.43x versus 0.55x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HIMSHims & Hers Health5.43x 62.74x $481.1M $26M SKINThe Beauty Health0.55x -- $83.5M -$10.3M
-
Which has Higher Returns HIMS or WALD?
Waldencast PLC has a net margin of 5.41% compared to Hims & Hers Health's net margin of --. Hims & Hers Health's return on equity of 32.03% beat Waldencast PLC's return on equity of -9.22%.
Company Gross Margin Earnings Per Share Invested Capital HIMSHims & Hers Health76.81% $0.11 $476.7M WALDWaldencast PLC-- -- $932M -
What do Analysts Say About HIMS or WALD?
Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 30.35%. On the other hand Waldencast PLC has an analysts' consensus of $5.56 which suggests that it could grow by 80%. Given that Waldencast PLC has higher upside potential than Hims & Hers Health, analysts believe Waldencast PLC is more attractive than Hims & Hers Health.
Company Buy Ratings Hold Ratings Sell Ratings HIMSHims & Hers Health4 7 1 WALDWaldencast PLC4 2 0 -
Is HIMS or WALD More Risky?
Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison Waldencast PLC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HIMS or WALD?
Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. Waldencast PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HIMS or WALD?
Hims & Hers Health quarterly revenues are $481.1M, which are larger than Waldencast PLC quarterly revenues of --. Hims & Hers Health's net income of $26M is higher than Waldencast PLC's net income of --. Notably, Hims & Hers Health's price-to-earnings ratio is 62.74x while Waldencast PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 5.43x versus 1.35x for Waldencast PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HIMSHims & Hers Health5.43x 62.74x $481.1M $26M WALDWaldencast PLC1.35x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
50
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
82
EXOD alert for Mar 20
Exodus Movement [EXOD] is up 17.89% over the past day.
Buy
69
SIG alert for Mar 20
Signet Jewelers [SIG] is down 0.64% over the past day.
Sell
36
HQY alert for Mar 20
HealthEquity [HQY] is up 0.28% over the past day.
